tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Positive Outlook for Cadrenal Therapeutics, Inc. Amid Strategic Developments and FDA Trial Milestone
PremiumRatingsPositive Outlook for Cadrenal Therapeutics, Inc. Amid Strategic Developments and FDA Trial Milestone
4M ago
Cadrenal Therapeutics Reports Increased Losses Amid R&D Expansion
Premium
Company Announcements
Cadrenal Therapeutics Reports Increased Losses Amid R&D Expansion
4M ago
Cadrenal Therapeutics Advances Tecarfarin Development in 2024
Premium
Company Announcements
Cadrenal Therapeutics Advances Tecarfarin Development in 2024
6M ago
Cadrenal Therapeutics files to sell 590K shares of common stock for holders
PremiumThe FlyCadrenal Therapeutics files to sell 590K shares of common stock for holders
10M ago
Cadrenal Therapeutics target adjusted to $32 from $3 at H.C. Wainwright
Premium
The Fly
Cadrenal Therapeutics target adjusted to $32 from $3 at H.C. Wainwright
10M ago
Cadrenal Therapeutics Advances Tecarfarin Development
Premium
Company Announcements
Cadrenal Therapeutics Advances Tecarfarin Development
10M ago
Cadrenal Therapeutics Inc trading resumes
PremiumThe FlyCadrenal Therapeutics Inc trading resumes
1y ago
Cadrenal Therapeutics Inc trading halted, volatility trading pause
Premium
The Fly
Cadrenal Therapeutics Inc trading halted, volatility trading pause
1y ago
Cadrenal Therapeutics Inc trading halted, news pending
Premium
The Fly
Cadrenal Therapeutics Inc trading halted, news pending
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100